DC Circ. Opens Door For Stem Cell Regulation By FDA

DC Circ. Opens Door For Stem Cell Regulation By FDA

The D.C. Circuit recently upheld a district court's ruling that autologous stem cells are a medical procedure subject to regulation by the U.S. Food and Drug Administration under the Federal Drug and Cosmetic Act and Public Health and Safety Act. ...read more

  • Tags: